SCHEMBL29983263

SCHEMBL29983263

CSc1c(B(O)O)ccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.46
PAK1 Q13153 1/20 0.46
CYP2A6 P11509 3/20 0.41
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HPRT1 P00492 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP1A2 P05177 2/20 0.36
PTPN22 Q9Y2R2 1/20 0.36
MAPT P10636 1/20 0.36
HIF1A Q16665 1/20 0.35
CYP1B1 Q16678 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19063379 1.00 USP2 (0.46) USP2PAK1CYP2A6ALDH1A1TDP1
SCHEMBL29983226 0.98 USP2 (0.44) USP2PAK1CYP2A6ALDH1A1TDP1
Ammonia Solution, Strong SCHEMBL28881581 0.98 USP2 (0.44) USP2PAK1CYP2A6ALDH1A1TDP1
SCHEMBL28937387 0.81 ALDH1A1 (0.43) CYP2A6ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL19082474 0.77 DNMT1 (0.33) USP2PAK1ALDH1A1HPRT1MEN1
SCHEMBL19110444 0.77 LMNA (0.41) CYP2A6ALDH1A1TDP1HSD17B10MEN1
SCHEMBL11660677 0.76 USP2 (0.70) USP2PAK1CYP2A6ALDH1A1TDP1
SCHEMBL25204022 0.75 DYRK1A (0.36) POLB
SCHEMBL30726251 0.75 DYRK1A (0.36) POLB
SCHEMBL30447387 0.75 MAPT (0.41) USP2PAK1CYP2A6ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115551838-B Novel compound and organic light emitting device using the same 株式会社LG化学 2024-11-26 CN disclosed
CN-115210228-B Compound and organic light emitting device including the same 株式会社LG化学 2024-11-01 CN disclosed
CN-113195481-B Compound and organic light emitting device comprising the same 株式会社LG化学 2024-09-27 CN disclosed
CN-113195480-B Compound and organic light-emitting element comprising same 株式会社LG化学 2024-09-06 CN disclosed
CN-113195479-B Compound and organic light emitting device comprising the same 株式会社LG化学 2024-09-03 CN disclosed
CN-113166133-B Compound and organic light emitting device comprising the same 株式会社LG化学 2024-08-27 CN disclosed
CN-117546629-A Organic light emitting device 株式会社LG化学 2024-02-09 CN disclosed
CN-117412977-A Novel compound and organic light emitting device comprising the same 株式会社LG化学 2024-01-16 CN disclosed
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 US disclosed
CN-116134983-A Organic light emitting device 株式会社LG化学 2023-05-16 CN disclosed
CN-115605464-A Novel compound and organic light emitting device comprising the same 株式会社LG化学(KR) 2023-01-13 CN disclosed
CN-115551838-A Novel compound and organic light emitting device using the same 株式会社LG化学 2022-12-30 CN disclosed
CN-115298843-A Organic light emitting device 株式会社LG化学 2022-11-04 CN disclosed
CN-115210228-A Novel compound and organic light emitting device including the same 株式会社LG化学 2022-10-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, AHR, CRY2 USP2 2925/4885PAK1 3485/4885CYP2A6 221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.